Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.07 USD | -4.39% | +0.06% | +127.43% |
May. 15 | Cullinan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Cullinan Therapeutics, Inc. Announces Board Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+127.43% | 1.39B | |
+51.30% | 63.85B | |
-2.21% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.55% | 26.52B | |
-21.47% | 18.69B | |
+2.91% | 12.73B | |
+21.82% | 12.11B | |
+27.92% | 12.07B |
- Stock Market
- Equities
- CGEM Stock
- News Cullinan Therapeutics, Inc.
- Cullinan Oncology : Morgan Stanley Upgrades Cullinan Management to Overweight from Equalweight, Sets $40 Price Target